Increasing Prevalence of Cervical Cancer to Augment the Cervical Cancer Vaccines Market Growth

Cervical Cancer Vaccines Market


 Cervical cancer is a type of cancer that starts in the cervix, a cavity that can be found in the vagina, uterus, or vulva. It is a sexually transmitted disease caused by the human papilloma virus. There are several strains of this virus, and each has a different name relating to the part of the body in which it affects. Most cervical cancers are associated with human papillomavirus (HPV), a sexually transmitted infection.

Extensive vaccination with the HPV vaccine may reduce the effects of cervical cancer across the world. HPV vaccines are vaccines that prevent infections by some varieties of the human papillomavirus. The two most commonly used vaccines are Gardasil and Cervarix, however, more vaccines are available now. Gardasil 9 is the U.S. FDA approved HPV vaccine and can be used for both girls and boys. HPV spread through sexual contact and is associated with most cases of cervical cancer.

Market Dynamics:

Increasing prevalence/incidence of cervical cancer across the world is expected to propel the growth of the cervical cancer vaccines market. For instance, around 140 new cases of cervical cancer in Minnesota in 2020, according to the American Cancer Society. Moreover, increasing government initiatives to increase awareness regarding cervical cancer and its treatments are expected to augment the growth of the cervical cancer vaccines market. For instance, the government of Rwanda (country in East Africa) planned to eradicate cervical cancer by 2020 by vaccinating all adolescents, especially girls, between the ages of 11 and 15. January is national cervical cancer awareness month.

North America and Asia Pacific are expected to witness robust growth in the market. The market due to the increasing prevalence of cervical cancer and increasing approval of cervical cancer vaccines by the regulatory bodies in these regions. For instance, according to the Centers for Disease Control and Prevention (CDC), each year, more than 13,000 women in the United States diagnosed with cervical cancer and 4,000 women die due to cervical cancer. However, high cost of the treatment of cervical cancer is expected to restrain the growth of the cervical cancer vaccines market.

Competitive Analysis:

Major players operating in the cervical cancer vaccines market are Merck & Co. Inc. and GlaxoSmithKline PLC.

Tampa Company, that has been researching and developing a vaccine for certain types of skin cancers, is expected to receive a grant to begin research on a cervical cancer treatment for underprivileged women.

Comments

Post a Comment

Popular posts from this blog

Bourbon Whiskey Is the Most Popular Whiskey in America and In Many Other Countries around the World

Image
  Whiskey or single malt whiskey is simply a form of distilled beverage made by distilling alcohol from grain mash or even by blending both. Different grains are utilized for different types, such as corn, barley, rye, and wheat. In Scotland, they call their whiskey black tea, a lighter caramel scotch, Irish cream, and liqueur. Whichever form is utilized, the result is usually a flavorful and smooth drink that has a distinct taste, and many people prefer a whiskey with a lower alcohol content. For example, single malt whiskey is the least expensive. The highest price however is the least distilled; that is Bourbon whiskey. Bourbon whiskey is the most popular whiskey in America and in many other countries around the world. Its price range is very wide, starting from as low as about US$ 12 a bottle to over a hundred dollars. So the price definitely varies. Whichever class you belong to, there is always a whiskey that will suit your preference. Single malt scotch whiskey is made ...
Read more

Viral Vectors And Plasmid DNA Manufacturing Market Is Gaining Major Traction With Oxford Biomedica Plc Entering Into A 3-Year Agreement With Boehringer Ingelheim For The Manufacture And Supply Of Various Types Of Viral Vectors

Image
  Viral Vectors are proteins that have been discovered to be essential for the spread of various viruses and infectious agents. These proteins can cause serious health risks if they are improperly introduced or if a wrong agent is used to fight them off. Viral vectors have often been used in various gene therapy procedures with the ultimate objective of curing various ailments in the biological fields of neurology, gene therapy, cancer, and metabolic disorder. Clinical studies regarding viral vectors remain one of the key factors in the manufacturing of viral vectors. Plasmids are used to deliver DNA contain genes for antibiotic resistance. In fact, scientists have developed many uses of plasmids and created software to record the DNA sequences of plasmids for applications in various techniques. Thus, such continuous R&D activities can potentially stimulate growth of the viral vectors and plasmid DNA manufacturing market . Recently, in April 2021, Oxford Biomedica plc entered...
Read more

Hard Surface Flooring Market Is Expected To Witness Robust Growth As Mohawk Industries Introduces Newly Imagined 30,000-Square Foot Floor Space At The International Surface Event (TISE)

Image
  There are many reasons why people choose hard surface floors over other types of flooring. Hard surfaces offer a level of durability and are very aesthetically pleasing. Unfortunately, choosing this type of flooring can be confusing and costly. There are four main hard surface varieties namely vinyl plank, laminate, solid hardwood, and engineered wood. Each has their own style strengths and provide different advantages. Increasing population coupled with rapid urbanization is expected to drive growth of the global hard surface flooring market . According to the United Nations (UN), by 2050, around 68% of the global population is expected to live in urban areas, increasing from 55% in 2018. According to the same source, in 2018, around 4.2 billion people were living in urban areas, increasing from 751 million in 1950. Furthermore, according to the World Bank, in 2019, the global population reached 7.674 billion, increasing from 6.84 billion in 2009. As a result of this, building...
Read more